Key result
With proper medical management, surveillance, and intervention, chronic type B aortic dissection can be managed effectively to minimize downstream morbidity.
Why the study?
Because medical therapy for uncomplicated acute type B aortic dissection often leads to chronic progression, reviewing the natural history, management, and intervention strategies is needed.
This review outlines the natural history, medical management, surveillance, and interventional strategies for chronic type B aortic dissection to minimize downstream morbidity.
May guide management of chronic type B aortic dissection; leaves open need for prospective trials to refine thresholds.
The standard of care first-line therapy for uncomplicated acute type B aortic dissection is medical therapy. As a result, many of these dissections progress to become chronic type B aortic dissections (CTBAD). In the following manuscript, we will outline the natural history of these lesions and review what constitutes a CTBAD by anatomy and chronology. We will also describe the long-term medical management and surveillance of these lesions, what constitutes high-risk features, and when intervention should be considered. Endovascular, open and hybrid management strategies, potential complications, and subsequently required surveillance will also be discussed. With proper medical management, surveillance, and intervention, CTBAD can be managed effectively and downstream morbidity minimized.
No takes yet. Share an insight, caveat, or question.
Trahanas et al. (2022) conducted a review in Chronic type B aortic dissection (CTBAD). Management strategies (medical, endovascular, open, hybrid) was evaluated. With proper medical management, surveillance, and intervention, chronic type B aortic dissection can be managed effectively to minimize downstream morbidity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: